Veterinary Medicines

Canigen CHPPi/L liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem

Authorised
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Download as PDF

Product identification

Medicine name:
Canigen CHPPi/L liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain Lederle, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle, Live
    100000.00
    50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    1000000.00
    50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Canine parvovirus, strain Cornell 780916, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain Manhattan, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    833000000.00
    unit(s)
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    833000000.00
    unit(s)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/00/1233
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/02/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/02/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/02/2025
Download